REF HOLDINGS(01631.HK)年度純利1826.6萬港元 同比減少45.54%
格隆匯 3 月 11日丨 REF HOLDINGS(01631.HK)發佈年度業績,截至2020年12月31日止年度,公司實現收益1.47億港元,同比減少22.57%;公司擁有人應占期內溢利1826.6萬港元,同比減少45.54%;基本每股盈利7.14港仙;董事會建議派付末期股息每股30港仙(2019年:無)。
回顧年度,香港經濟面對社會動盪、爆發COVID-19及中美貿易糾紛持續等前所未有的挑戰。在此關鍵時刻,集團將員工、客户及業務夥伴的健康與安全置於首位。儘管如此,公司相信一站式服務模式可為客户提供周全質優的全方位服務,既能招攬新客户,亦能迅速回應客户不斷轉變的需要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.